Correspondent
Gety picturesA study indicates that drug therapy can help people who have recently been diagnosed with hyperactivity disorder and attention (hyperactivity disorder in attention deficit) to reduce the risk of misuse of substances, suicide behavior, transport accidents and criminality.
These problems are associated with symptoms of hyperactivity disorder and common attention lack, such as acting intermittently and easily behaving.
It is believed that about 5 % of children and 2.5 % of adults all over the world are affected by the turmoil – and the increasing numbers are diagnosed.
The researchers say the results, published in the British Medical Journal (BMJ), confirm the broader potential benefits of drug therapy and can help patients determine whether the drug will be started.
The presence of hyperactivity and attention disorder means that the brain works differently for most others.
Symptoms can include difficulties in focusing and sitting, with high levels of energy and impulsivity.
Despite the increase in people who ask for help, the disorder does not become more common. Last year, the BBC investigation was found long for the UK evaluation.
People are diagnosed only if the symptoms cause a moderate effect on their lives.
The most commonly prescribed medications, called doping, helps in managing daily symptoms, but there was limited evidence of the long -term benefits of people’s behavior, while the well -classified side effects such as headache, loss of appetite and troubles have sparked a discussion about their safety.
This BMJ’s study was based on 148,500 people between the ages of six to 64 years, with hyperactivity disorder and a lack of attention in Sweden.
About 57 % began to treat drugs, and from these, Methelinidit (also known as Ritalin)It was identified, to 88 %.
The researchers, from the University of Southampton and the Carolinska Institute in Stockholm, found that taking hyperactivity and attention disorder medications linked to the first time discounts:
- Suicide behavior – 17 %
- Articles misuse – 15 %
- Transport accidents – 12 %
- Crime behavior – 13 %
When repeated events were analyzed, researchers found that ADHD drugs are linked to discounts:
- 15 % for suicide attempts
- 25 % for the use of the material
- 4 % for accidental injuries
- 16 % for transport accidents
- 25 % for criminal behavior
“Often, there is no information about what the risks are if you do not treat hyperactivity and attention lack,” said Professor Samuel Cortez, author of the psychiatry study for children and adolescents at the University of Southampton.
“Now we have evidence [drugs] It can reduce these risks. “
This can be explained by medications that reduce impulsive behavior and lack of concentration, which may reduce the risk of accidents while driving and reduce aggressive behavior that may lead to criminality.
The researchers say that the study was designed to be as strong as possible, but it cannot exclude the possibility of results affected by factors such as the genes of people, lifestyles, the severity of hyperactivity disorder and attention lack.
It is not easy to access the appropriate drug for ADHD in many countries, with some medications that are displayed. At waiting times in the UK to see specialists after the diagnosis for access to medicines can be several years.
Professor Stewart Kenner, head of the Justice Health Group at Curtin University in Western Australia, said the research showed “the benefits spread to the diagnosis and treatment of hyperactivity disorder and attention lack.”
“The failure to diagnose and treat hyperactivity disorder and attention lack can lead to self -distinction with alcohol or other drugs, poor mental health, injury, and imprisonment,” he said.
“Many people with hyperactivity disorder and lack of attention lack in the criminal justice system end, as their condition may remain unjustified and not tackled.”
Ian Midmint, a professor of clinical pharmacy at Aston University, said that the study “adds to our understanding of the potential benefits of these drugs.”
However, he said that the research did not evaluate whether the patients had already taken their medications or the effect of various doses.